Citation Impact
Citing Papers
Burn wound healing and treatment: review and advancements
2015 Standout
The multifaceted role of pirfenidone and its novel targets
2010
Idiopathic pulmonary fibrosis
2017 Standout
Pirfenidone Treatment Decreases Transforming Growth Factor-β1 and Matrix Proteins and Ameliorates Fibrosis in Chronic Cyclosporine Nephrotoxicity
2002
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
1999
Vagus-Dependent and Vagus-Independent Mechanisms of Action of the Erythromycin Derivative EM574 and Motilin in Dogs
1996 StandoutNobel
Improving drug solubility for oral delivery using solid dispersions
2000 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Cisapride
1994
Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
2007
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
1996 Standout
Treatment of chronic kidney disease
2011
Mechanisms of Tubulointerstitial Fibrosis
2010
Mycophenolate mofetil and its mechanisms of action
2000 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate
2000
Effect of 2-Hydroxypropyl-β-cyclodextrin on Crystallization and Polymorphic Transition of Nifedipine in Solid State
1994
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Metabolomic profiling of uremic solutes in CKD patients
2010
Basics and Applications of Solid-State Kinetics: A Pharmaceutical Perspective**The authors dedicate this review to the memory of Dr. David J.W. Grant who passed away on December 9, 2005. Dr. Grant was an internationally known authority at the University of Minnesota on the solid-state properties of drugs. He will be remembered as a kind, humble, and brilliant scholar.
2006
Antifibrotic activities of pirfenidone in animal models
2011
Mexiletine
1998
Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation
1998
Cyclodextrin Drug Carrier Systems
1998 Standout
Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals
1995 Standout
Impurities in tokamaks
1984
Spectroscopic study of impurity behaviour in neutral beam heated and ohmically heated TFTR discharges
1987 StandoutNobel
Observation ofz-dependent impurity accumulation in the PBX tokamak
1987 StandoutNobel
Plasma-material interactions in current tokamaks and their implications for next step fusion reactors
2001 Standout
The electron cyclotron maser
2004 Standout
Solubility Advantage of Pharmaceutical Cocrystals
2009 Standout
Passive high-power microwave components
2002
Impurity transport in ohmic and neutral-beam-heated TFTR discharges
1987 StandoutNobel
Diabetic Somatic Neuropathies
2004 Standout
Solid-State Kinetic Models: Basics and Mathematical Fundamentals
2006 Standout
Impurity transport during the H-mode in DIII-D
1991 StandoutNobel
Crystal growth, polymorphism and structure-property relationships in organic crystals
1993
Works of T. Kuroda being referenced
Effects of Cisapride on Gastrointestinal Motor Activity and Gastric Emptying of Disopyramide.
1992
A kinetic study on the isothermal transition of polymorphic forms of tolbutamide and mefenamic acid in the solid state at high temperatures.
1985
Heating in Toroidal Plasmas
1984
Interaction between Diltiazem and Antiarrhythmic Drugs: Aprindine and Mexiletine.
1994
Studies on drug nonequivalence. X. Bioavailability of 6-mercaptopurine polymorphs.
1981
Antenna and transmission system for high power electron cyclotron heating in a compact helical system
1995
Hybrid mode trasmission in 62-m corrugated waveguide
1994
Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy.
1997
Kinetics of the Thermal Transition of Carbamazepine Polymorphic Forms in the Solid State
1984